Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117282) titled 'Application of IMB-based Continuity Care Service in Home Oral Targeted Drug Administration for Elderly Patients with Hepatocellular Carcinoma' on Jan. 22.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Qilu Hospital, Shandong University,
Condition:
Hepatocellular carcinoma cells
Intervention:
Control group:The control group received routine discharge education, including medication guidance upon discharge and explanation of the follow-up schedule. The intervention period for the control group was from admission to 3 months post-intervention. Outpatient follow-up and m...